Opko Health Inc. (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 50,000 shares of the stock in a transaction dated Wednesday, June 11th. The shares were purchased at an average price of $9.09 per share, for a total transaction of $454,500.00. Following the transaction, the chief executive officer now directly owns 1,987,500 shares of the company’s stock, valued at approximately $18,066,375. Opko Health Inc. (NYSE:OPK) weekly performance is 2.82%. On last trading day company shares ended up $9.47. Analysts mean target price for the company is $12.25. Opko Health Inc. (NYSE:OPK) distance from 50-day simple moving average (SMA50) is 9.97%.
Republic Services Inc. (NYSE:RSG) major shareholder Cascade Investment Llc purchased 205,300 shares of the stock on the open market in a transaction that occurred on Friday, June 13th. The stock was purchased at an average price of $36.68 per share, for a total transaction of $7,530,404.00. Following the completion of the transaction, the insider now directly owns 90,061,442 shares in the company, valued at approximately $3,303,453,693. Republic Services, Inc. (NYSE:RSG) shares advanced 0.71% in last trading session and ended the day on $36.93. RSG gross Margin is 37.20% and its return on assets is 3.00%.Republic Services, Inc. (NYSE:RSG) quarterly performance is 9.10%.
Prospect Capital Corporation (NASDAQ:PSEC) CEO John F. Barry acquired 100,000 shares of the company’s stock on the open market in a transaction that occurred on Friday, June 13th. The shares were purchased at an average cost of $10.37 per share, with a total value of $1,037,000.00. Following the acquisition, the chief executive officer now directly owns 4,110,959 shares in the company, valued at approximately $42,630,645. Prospect Capital Corporation (NASDAQ:PSEC) shares moved up 0.78% in last trading session and was closed at $10.34, while trading in range of $10.30 – $10.38. Prospect Capital Corporation (NASDAQ:PSEC) year to date (YTD) performance is -3.00%.
Insys Therapeutics Inc. (NASDAQ:INSY) Director John N. Kapoor acquired 20,000 shares of Insys Therapeutics stock on the open market in a transaction dated Wednesday, June 11th. The shares were purchased at an average price of $24.54 per share, with a total value of $490,800.00. Following the transaction, the director now directly owns 15,991 shares of the company’s stock, valued at approximately $392,419. Insys Therapeutics Inc. (NASDAQ:INSY) ended the last trading day at $29.70. Company weekly volatility is calculated as 8.55% and price to cash ratio as 21.68.Insys Therapeutics Inc. (NASDAQ:INSY) showed a positive weekly performance of 18.23%.
Alfred Hurley Jr., director of New Mountain Finance Corp. (NYSE:NMFC), purchased 6,970 of the company’s shares through two separate transactions and now owns a total of 23,112.87 shares, directly. Furthermore, the firm’s Chief Compliance Officer, Paula Bosco, acquired 623 shares at the same price, bringing her total company shares up to 13,897.13. New Mountain Finance Corp. (NYSE:NMFC) net profit margin is 66.10% and weekly performance is 2.20%. On last trading day company shares ended up $14.37. Analysts mean target price for the company is $15.31. New Mountain Finance Corp. (NYSE:NMFC) distance from 50-day simple moving average (SMA50) is 2.84%.